- Home
- INDV vs EMAT Comparison
INDV vs EMAT Comparison
Compare INDV & EMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INDV | EMAT |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.4B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | INDV | EMAT |
|---|---|---|
| Price | $40.48 | $5.29 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $30.00 |
| AVG Volume (30 Days) | ★ 1.6M | 74.9K |
| Earning Date | 06-08-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8100.00 | N/A |
| EPS | ★ 0.69 | N/A |
| Revenue | ★ $1,239,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2,122.43 |
| P/E Ratio | $56.70 | ★ N/A |
| Revenue Growth | ★ 4.29 | N/A |
| 52 Week Low | $16.14 | $4.88 |
| 52 Week High | $42.81 | $17.50 |
Technical Indicators
Market Signals| Indicator | INDV | EMAT |
|---|---|---|
| Relative Strength Index (RSI) | 52.62 | 34.98 |
| Support Level | $39.20 | N/A |
| Resistance Level | $41.00 | $7.62 |
| Average True Range (ATR) | 1.48 | 0.41 |
| MACD | -0.23 | -0.03 |
| Stochastic Oscillator | 47.74 | 20.73 |
Price Performance
Historical ComparisonAbout INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
About EMAT Evolution Metals & Technologies Corp. Common Stock
Evolution Metals & Technologies Corp is a critical materials and technology company. The company is focused on developing a secure, dependable, and self-sustaining U.S.-aligned supply chain for critical minerals and materials (CMM), and rare earth elements (REEs). The company is also engaged in recycling end-of-life materials through urban mining to help strengthen domestic resource independence and long-term supply stability.